0
Sign In
|
POL Subscriptions
Home
DSM Library
DSM-5®
DSM-IV-TR®
DSM-IV-TR® Handbook of Differential Diagnosis
DSM Cases
Books
The American Psychiatric Publishing Textbook of Psychiatry
Gabbard's Treatments of Psychiatric Disorders
Textbook of Psychotherapeutic Treatments
The American Psychiatric Publishing Textbook of Geriatric Psychiatry
Dulcan's Textbook of Child and Adolescent Psychiatry
The American Psychiatric Publishing Textbook of Substance Abuse Treatment
The American Psychiatric Publishing Textbook of Psychopharmacology
Manual of Clinical Psychopharmacology
Textbook of Traumatic Brain Injury
Journals
The American Journal of Psychiatry
Psychiatric Services
The Journal of Neuropsychiatry and Clinical Neurosciences
Academic Psychiatry
FOCUS
Psychiatric News
Topics
APA Guidelines
CME & Self-Assessment
News
For Patients
What Your Patients Need to Know About Psychiatric Medications
Helping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional Problems: A Resource Book of Medication Information Handouts
Let's Talk Facts
My POL
Advanced Search
Home
Current Issue
All Issues
Topics
About
Residents' Journal
13
The American Journal of Psychiatry, VOL. 138, No. 10
1
AJP
Letters to the Editor
|
October 01, 1981
Neuroleptics, Antiparkinsonian Medication, and Schizophrenia
JAMES E. NININGER
Am J Psychiatry 1981;138:1389-1389.
View Author and Article Information
New York, N.Y.
1981, the American Psychiatric Association
Article
text
A
A
A
No abstract is available for this article
+
References
+
+
CME Activity
There is currently no quiz available for this resource. Please
click here to go to the CME page
to find another.
Loading...
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.
*
= Required Field
Comment Author(s)
*
(if multiple authors, separate names by comma)
Example: John Doe
Affiliation & Institution
*
Comment Title
*
Comment
*
Cancel
Print
E-mail
Recipient(s) will receive an email with a link (good for 72 hours) to '
Neuroleptics, Antiparkinsonian Medication, and Schizophrenia
' and do not need to have American Journal of Psychiatry account to access the content.
Your Name:
*
Example: John Doe
Email Address:
*
CC Me:
Enter your valid email address. Example: jdoe@example.com
Recipient's Email Address:
*
Separate multiple email address with semi-colons (up to 5).
Subject:
*
's American Journal of Psychiatry: 'Neuroleptics, Antiparkinsonian Medication, and Schizophrenia'
Subject for your email.
Message:
(Optional, message will truncate at 1000 characters)
Processing your request... Please Wait...
Copyright © in the material you requested is held by The American Psychiatric Association (unless otherwise noted). This email ability is provided as a courtesy, and by using it you agree that you are requesting the material solely for personal, non-commercial use, and that it is subject to The American Psychiatric Association's
Terms of Use
. The information provided in order to email this topic will not be used to send unsolicited email, nor will it be furnished to third parties. Please refer to The American Psychiatric Association's
Privacy Policy
for further information.
Copyright © American Psychiatric Association. All rights reserved.
Share
Get Citation
JAMES E. NININGER; Neuroleptics, Antiparkinsonian Medication, and Schizophrenia. American Journal of Psychiatry. 1981 Oct;138(10):1389-1389.
Download citation file:
RIS (Zotero)
EndNote
BibTex
Medlars
ProCite
RefWorks
Reference Manager
Copyright © American Psychiatric Association. All rights reserved.
Reprints
Related Content
Articles
Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar and Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study
Am J Psychiatry
17 June 2013
Diffusion Tensor Imaging White Matter Endophenotypes in Patients With Schizophrenia or Psychotic Bipolar Disorder and Their Relatives
Am J Psychiatry
17 June 2013
Cluster-Randomized Controlled Trial of Reducing Seclusion and Restraint in Secured Care of Men With Schizophrenia
Psychiatric Services
14 June 2013
Anatomical and Functional Brain Abnormalities in Drug-Naive First-Episode Schizophrenia
Am J Psychiatry
4 June 2013
A+KIDS, a Web-Based Antipsychotic Registry for North Carolina Youths: An Alternative to Prior Authorization
Psychiatric Services
3 June 2013
[+] View More
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 1. >
Legal, Ethical, and Economic Issues
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 2. >
Schizophrenia and Other Schizophrenia Spectrum Disorders
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 4. >
Antipsychotic Drugs
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 4. >
General Principles of Antipsychotic Use
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 4. >
Second-Generation (Atypical) Antipsychotics
[+] View More
Topic Collections
Pharmacotherapy
Antipsychotics
Schizophrenia and Other Psychotic Disorders
Psychiatric News
Psychiatric News Home
Optimism Grows About Potential to Aid Schizophrenia Cognition
3 June 2013 doi:10.1176/appi.pn.2013.6a7
Social Cognition in Schizophrenia May Improve With Oxytocin
17 May 2013 doi:10.1176/appi.pn.2013.5b12
Product Theaters Offered on Variety of Topics
3 May 2013 doi:10.1176/appi.pn.2013.5a15
Med Check
3 May 2013 doi:10.1176/appi.pn.2013.5a8
Folate Gene Variants May Influence Negative Schizophrenia Symptoms
5 April 2013 doi:10.1176/appi.pn.2013.4a2
[+] View More
Read more at
Psychiatric News >>
APA Guidelines
TREATING SCHIZOPHRENIAA Quick Reference Guide
Guideline Watch (September 2009): Practice Guideline for the Treatment of Patients With Schizophrenia
TREATING BIPOLAR DISORDERA Quick Reference Guide
[+] View More
PubMed Articles
Olanzapine vs haloperidol for treatment of schizophrenia.
JAMA : the journal of the American Medical Association 2004 Mar 3
Olanzapine vs haloperidol for treatment of schizophrenia.
JAMA : the journal of the American Medical Association 2004 Mar 3
You do not have access to this content.
You either do not have a subscription or your subscription has expired.
Click here
to Renew Now
Copyright ©
American
Psychiatric
Association